Germany’s Secarna Pharmaceuticals has appointed Konstantin Petropoulos as CEO. He is stepping up from his previous role as the company’s chief business officer (CBO) and...
US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the...
27.03.2020
- Secarna Pharmaceuticals, a German biopharmaceuticals company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address...
10.09.2018
- Germany’s Secarna Pharmaceuticals and Firebrand Therapeutics of the US have entered a co-development agreement for novel cancer therapies. The target is to combine Secarna's...
